» Articles » PMID: 19664713

Structure and Function of the Blood-brain Barrier

Overview
Journal Neurobiol Dis
Specialty Neurology
Date 2009 Aug 12
PMID 19664713
Citations 2030
Authors
Affiliations
Soon will be listed here.
Abstract

Neural signalling within the central nervous system (CNS) requires a highly controlled microenvironment. Cells at three key interfaces form barriers between the blood and the CNS: the blood-brain barrier (BBB), blood-CSF barrier and the arachnoid barrier. The BBB at the level of brain microvessel endothelium is the major site of blood-CNS exchange. The structure and function of the BBB is summarised, the physical barrier formed by the endothelial tight junctions, and the transport barrier resulting from membrane transporters and vesicular mechanisms. The roles of associated cells are outlined, especially the endfeet of astrocytic glial cells, and pericytes and microglia. The embryonic development of the BBB, and changes in pathology are described. The BBB is subject to short and long-term regulation, which may be disturbed in pathology. Any programme for drug discovery or delivery, to target or avoid the CNS, needs to consider the special features of the BBB.

Citing Articles

Role of FPR2 antagonism in alleviating social isolation-induced depression and protecting blood-brain barrier integrity.

Zheng J, Wang H, Wu W, Wang L, Qin M, Zhu L J Neuroinflammation. 2025; 22(1):79.

PMID: 40083006 PMC: 11907847. DOI: 10.1186/s12974-025-03408-4.


A Posteriori Error Analysis for a Coupled Stokes-Poroelastic System with Multiple Compartments.

Fumagalli I, Parolini N, Verani M J Sci Comput. 2025; 103(1):22.

PMID: 40065827 PMC: 11890245. DOI: 10.1007/s10915-025-02814-3.


Ultrasound mediated blood-brain barrier opening increases brain tumor biomarkers: A review of preclinical and clinical trials.

Izhar M, Thakur A, Park D, Chang S J Liq Biopsy. 2025; 6:100277.

PMID: 40027314 PMC: 11863884. DOI: 10.1016/j.jlb.2024.100277.


The blood-brain barriers: novel nanocarriers for central nervous system diseases.

Liu J, Wang T, Dong J, Lu Y J Nanobiotechnology. 2025; 23(1):146.

PMID: 40011926 PMC: 11866817. DOI: 10.1186/s12951-025-03247-8.


Current Trends in Clinical Trials of Prodrugs.

Boreski D, Schmid V, Bosquesi P, Dos Santos J, Scarim C, Reshetnikov V Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006024 PMC: 11859331. DOI: 10.3390/ph18020210.